In fact, all three variables–tau, glucose metabolism in typically affected AD regions, and hippocampal volume–were related to one another at baseline and to a large extent in longitudinal relationships (although baseline p-Tau/Aβ40 predicted metabolic decline but not progressive atrophy). This evidence concerns the gene MAPT and Alzheimer disease.